BG
ABMD

BlackRock Group’s Abiomed Inc ABMD Stock Holding History

BlackRock Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.96M Buy
35,129
+1,659
+5% +$192K ﹤0.01% 1317
2016
Q3 		$4.3M Sell
33,470
-15,872
-32% -$1.9M ﹤0.01% 1179
2016
Q2 		$5.39M Buy
49,342
+18,699
+61% +$1.86M ﹤0.01% 1071
2016
Q1 		$2.9M Sell
30,643
-18,185
-37% -$1.54M ﹤0.01% 1313
2015
Q4 		$4.41M Buy
48,828
+2,402
+5% +$204K ﹤0.01% 1137
2015
Q3 		$4.31M Sell
46,426
-3,890
-8% -$343K ﹤0.01% 1159
2015
Q2 		$3.31M Buy
50,316
+6,404
+15% +$425K ﹤0.01% 1303
2015
Q1 		$3.14M Buy
43,912
+4,563
+12% +$248K ﹤0.01% 1294
2014
Q4 		$1.5M Sell
39,349
-115
-0.3% -$3.63K ﹤0.01% 1636
2014
Q3 		$980K Sell
39,464
-1,067
-3% -$27K ﹤0.01% 1800
2014
Q2 		$1.02M Sell
40,531
-15,150
-27% -$353K ﹤0.01% 1822
2014
Q1 		$1.45M Sell
55,681
-2,840
-5% -$78.6K ﹤0.01% 1797
2013
Q4 		$1.56M Sell
58,521
-21,246
-27% -$525K ﹤0.01% 1695
2013
Q3 		$1.52M Buy
79,767
+10,482
+15% +$240K ﹤0.01% 1648
2013
Q2 		$1.49M Buy
+69,285
New +$1.39M ﹤0.01% 1465

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Group's ABMD Position: Q4 2016 in Review

BlackRock Group increased its Abiomed Inc (ABMD) stake by 5% in Q4 2016, buying an estimated $192K and bringing the position to 35,129 shares worth $3.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1317.

BlackRock Group first reported a position in ABMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.39M in Q2 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • BlackRock Group held 35,129 shares of Abiomed Inc worth $3.96M as of Q4 2016.
  • BlackRock Group bought 1,659 Abiomed Inc shares in Q4 2016, an estimated $192K.
  • Abiomed Inc made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1317 holding.
  • BlackRock Group first reported a position in Abiomed Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Abiomed Inc position peaked at $5.39M in Q2 2016.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.